Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medtronic PLC (MDT) vs Standard Lithium Ltd (SLI) Price & Performance

Medtronic PLCTrade
Standard Lithium LtdTrade

Price performance (Past 24H)

Key statistics

Medtronic PLC vs Standard Lithium Ltd — how do they compare? Medtronic PLC trades at $82.29 (market cap $106.61B), while Standard Lithium Ltd trades at $2.29 (market cap $523.89M). The key difference: Medtronic PLC is far larger — about 203.5× Standard Lithium Ltd's market cap, and Medtronic PLC pays a 3.46% dividend while Standard Lithium Ltd pays none. Which is the better fit depends on your goals.

MDTSLI
Market Cap
$106.61B$523.89M
Sector
HealthBasic Materials
52-Week High
$105.35$5.65
52-Week Low
$73.75$2.15
Enterprise Value
$125.36B$383.09M
Dividend Yield
3.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medtronic PLC

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Standard Lithium Ltd

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT

About Standard Lithium Ltd

Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.

Read more on SLI